Hantz Financial Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.81M Buy
27,376
+383
+1% +$53.6K 0.06% 226
2025
Q4
$3.31M Sell
26,993
-167
-0.6% -$20.3K 0.05% 247
2025
Q3
$3.02M Sell
27,160
-883
-3% -$100K 0.05% 268
2025
Q2
$3.11M Sell
28,043
-1,080
-4% -$115K 0.05% 268
2025
Q1
$3.26M Sell
29,123
-34,443
-54% -$3.55M 0.06% 259
2024
Q4
$5.87M Sell
63,566
-7,260
-10% -$654K 0.1% 195
2024
Q3
$5.94M Sell
70,826
-2,422
-3% -$185K 0.11% 197
2024
Q2
$5.03M Sell
73,248
-4,224
-5% -$282K 0.1% 207
2024
Q1
$5.67M Sell
77,472
-26,653
-26% -$2.05M 0.11% 200
2023
Q4
$8.44M Sell
104,125
-6,026
-5% -$469K 0.18% 161
2023
Q3
$8.26M Buy
110,151
+42,979
+64% +$3.31M 0.21% 144
2023
Q2
$5.18M Buy
67,172
+400
+0.6% +$31.9K 0.13% 193
2023
Q1
$5.54M Buy
66,772
+1,063
+2% +$88K 0.15% 177
2022
Q4
$5.64M Buy
65,709
+2,903
+5% +$230K 0.17% 169
2022
Q3
$3.87M Buy
62,806
+1,586
+3% +$100K 0.13% 195
2022
Q2
$3.78M Buy
61,220
+2,701
+5% +$167K 0.13% 197
2022
Q1
$3.48M Buy
58,519
+3,906
+7% +$250K 0.1% 220
2021
Q4
$3.96M Buy
54,613
+3,117
+6% +$215K 0.11% 197
2021
Q3
$3.6M Buy
51,496
+5,805
+13% +$408K 0.12% 197
2021
Q2
$3.15M Buy
45,691
+3,343
+8% +$223K 0.12% 200
2021
Q1
$2.74M Buy
42,348
+533
+1% +$34.4K 0.11% 209
2020
Q4
$2.44M Buy
41,815
+270
+0.6% +$16.3K 0.11% 207
2020
Q3
$2.63M Sell
41,545
-576
-1% -$39.9K 0.13% 189
2020
Q2
$3.24M Buy
42,121
+770
+2% +$59K 0.18% 166
2020
Q1
$3.09M Buy
+41,351
New +$2.86M 0.21% 148

Other funds holding GILD

Hantz Financial Services's GILD Position: Q1 2026 in Review

Hantz Financial Services increased its Gilead Sciences (GILD) stake by 1.4% in Q1 2026, buying an estimated $53.6K and bringing the position to 27,376 shares worth $3.81M. The position accounts for 0.06% of the portfolio, ranked #226.

Hantz Financial Services first reported a position in GILD in Q1 2020 and has held it in 25 quarters since. The position peaked at $8.44M in Q4 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Hantz Financial Services held 27,376 shares of Gilead Sciences worth $3.81M as of Q1 2026.
  • Hantz Financial Services bought 383 Gilead Sciences shares in Q1 2026, an estimated $53.6K.
  • Gilead Sciences made up 0.06% of Hantz Financial Services's portfolio in Q1 2026, its #226 holding.
  • Hantz Financial Services first reported a position in Gilead Sciences in Q1 2020 and has held it in 25 quarters since.
  • Hantz Financial Services's Gilead Sciences position peaked at $8.44M in Q4 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Hantz Financial Services's 13F filing for Q1 2026, filed 1 May 2026.